Gavazzi Francesca, Ridolfi Cristina, Capretti Giovanni, Angiolini Maria Rachele, Morelli Paola, Casari Erminia, Montorsi Marco, Zerbi Alessandro
Pancreatic Surgery Unit, Department of Surgery, Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Infectious Diseases Unit, Hospital Health Direction, Humanitas Research Hospital, Rozzano, Italy.
BMC Gastroenterol. 2016 Mar 31;16:43. doi: 10.1186/s12876-016-0460-1.
The routine use of preoperative biliary drainage before pancreaticoduodenectomy (PD) remains controversial. This observational retrospective study compared stented and non-stented patients undergoing PD to assess any differences in post-operative morbidity and mortality.
A total of 180 consecutive patients who underwent PD and had intra-operative bile cultures performed between January 2010 and February 2013 were retrospectively identified. All patients received peri-operative intravenous antibiotic prophylaxis, primarily cefazolin.
Overall incidence of post-operative surgical complications was 52.3 %, with no difference between stented and non-stented patients (53.4 % vs. 51.1 %; p = 0.875). However, stented patients had a significantly higher incidence of deep incisional surgical site infections (SSIs) (p = 0.038). In multivariate analysis, biliary stenting was confirmed as a risk factor for deep incisional SSIs (p = 0.044). Significant associations were also observed for cardiac disease (p = 0.010) and BMI ≥25 kg/m(2) (p = 0.045). Enterococcus spp. were the most frequent bacterial isolates in bile (74.5 %) and in drain fluid (69.1 %). In antimicrobial susceptibilty testing, all Enterococci isolates were cefazolin-resistant.
Given the increased risk of deep incisional SSIs, preoperative biliary stenting in patients underging PD should be used only in selected patients. In stented patients, an antibiotic with anti-enterococcal activity should be chosen for PD prophylaxis.
胰十二指肠切除术(PD)前常规进行术前胆道引流仍存在争议。这项观察性回顾性研究比较了接受PD的置支架患者和未置支架患者,以评估术后发病率和死亡率的差异。
回顾性确定了2010年1月至2013年2月期间连续接受PD并进行术中胆汁培养的180例患者。所有患者均接受围手术期静脉抗生素预防,主要是头孢唑林。
术后手术并发症的总体发生率为52.3%,置支架患者和未置支架患者之间无差异(53.4%对51.1%;p = 0.875)。然而,置支架患者深部切口手术部位感染(SSIs)的发生率显著更高(p = 0.038)。在多变量分析中,胆道支架置入被确认为深部切口SSIs的一个危险因素(p = 0.044)。还观察到与心脏病(p = 0.010)和BMI≥25 kg/m²(p = 0.045)有显著关联。肠球菌属是胆汁(74.5%)和引流液(69.1%)中最常见的细菌分离株。在抗菌药敏试验中,所有肠球菌分离株均对头孢唑林耐药。
鉴于深部切口SSIs风险增加,接受PD的患者术前胆道支架置入应仅用于特定患者。对于置支架患者,应选择具有抗肠球菌活性的抗生素用于PD预防。